Compare Adaptive Biotechnologies Corp (ADPT) vs Hilton Hotels Corporation Common Stock (HLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Hilton Hotels Corporation Common Stock — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Hilton Hotels Corporation Common Stock trades at $316.39 (market cap $70.82B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 17.5× Adaptive Biotechnologies Corp's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | HLT | |
|---|---|---|
Market Cap | $4.04B | $70.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $350.22 |
52-Week Low | $12.30 | $256.75 |
Enterprise Value | $4.10B | $83.83B |
Dividend Yield | — | 0.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Hilton Hotels Corporation Common Stock
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →
